Bay Area biotechs, including one with a big St. Louis investor, map out IPO plans
Cancer-fighting Spruce, targeting a serious hormonal condition, has a St. Louis investor.
Cancer-fighting Spruce, targeting a serious hormonal condition, has a St. Louis investor.